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Selective serotonergic reuptake inhibitors (SSRIs) and cognitive therapies are effective in the treatment of anxiety and depression.
Previous research suggests that both forms of treatments may work by altering cognitive biases in the processing of affective information.
The current study assessed the effects of combining an SSRI with a cognitive intervention on measures of affective processing bias and
resilience to external challenge. A total of 62 healthy participants were randomly assigned to receive either 7 days of citalopram (20mg)
or placebo capsules while also completing either an active or a control version of a computerized cognitive bias training task. After
treatment, standard measures of affective processing bias were collected. Participants’ resilience to external stress was also tested by
measuring the increase in negative symptoms induced by a negative mood induction. Participants who received both citalopram and the
active cognitive bias training task showed a smaller alteration in emotional memory and categorization bias than did those who received
either active intervention singly. The degree to which memory for negative information was altered by citalopram predicted participants’
resistance to the negative mood induction. These results suggest that co-administration of an SSRI and a cognitive training intervention
can reduce the effectiveness of either treatment alone in terms of anxiety- and depression-relevant emotional processing. More generally,
the findings suggest that pinpointing the cognitive actions of treatments may inform future development of combination strategies in
mental health.
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INTRODUCTION
Cognitive models of anxiety and depression highlight the
role of affective information-processing biases, such as the
tendency to focus selectively on negative at the expense of
positive information, in the etiology and maintenance of
disorders (Beck et al, 1985; Mathews and MacLeod, 2005).
These models predict that interventions that reduce
negative processing biases will improve symptoms of
emotional disorders by increasing resilience to challenging
external events. Consistent with this proposal, antidepres-
sant medications, which are effective in the treatment of
anxiety and depression (NICE, 2007, 2009), have been
demonstrated to reduce negative and to increase positive
biases in non-clinical groups (Harmer et al, 2003; Murphy
et al, 2009). The medications seem to have a very similar
effect in clinical populations (Harmer et al, 2009; Tranter
et al, 2009), suggesting that healthy volunteer studies may
be usefully used as a model of the cognitive effects of
pharmacological treatments in patients and thus be useful
in testing and developing new therapeutic interventions
(Harmer, 2008; Harmer et al, 2011).
Psychological treatments such as cognitive behavioral
therapy (CBT) have also been reported to influence these
kinds of emotional processing measures (Mathews et al,
1995). In addition, more targeted and often implicit
cognitive training interventions (MacLeod et al, 2009) have
recently been developed with the specific goal of reducing
negative and increasing positive biases (see Figure 1c for a
description of a cognitive bias training task). These simple,
computer-based training tasks have been found to alter
processing biases (eg, in attention) in both non-clinical
(Browning et al, 2010b; MacLeod et al, 2002) and clinical
groups (Amir et al, 2009) and, importantly, have also
been found to reduce self-reported symptoms of anxiety
and depression (Hakamata et al, 2010; Wells and Beevers,
2009). It is also more straightforward to devise neutral
control tasks for training regimes than for complex Received 11 April 2011; revised 2 July 2011; accepted 8 July 2011
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themselves much better to the controlled investigations of
treatment mechanisms.
The results reviewed above suggest that alteration of
processing biases, from negative to positive, is a common
factor in the therapeutic effects of both pharmacological
and cognitive treatments for emotional disorders (Browning
et al, 2010a). In the current study, we extended this work by
examining how two specific forms of treatments interact;
thus, we assessed whether combining a pharmacological
and a cognitive treatment leads to an enhanced or
diminished effect on processing bias when compared with
individually administered treatments.
The mechanisms underlying treatment interactions are of
obvious clinical interest as regimes combining pharmaco-
logical and psychological interventions are a recognized
treatment option in both depression and anxiety (NICE,
2007, 2009). Interestingly, although some evidence from
clinical trials in adults does suggest an acute advantage of
combination over individually administered treatments
(Keller et al, 2000), the advantage conferred seems to be
somewhat inconsistent (Cuijpers et al, 2009a; Foa et al,
2002; Furukawa et al, 2007; Pampallona et al, 2004),
particularly when the psychological intervention is CBT
(Cuijpers et al, 2009b). Indeed, there is evidence to suggest
that addition of antidepressants to CBT may reduce the
durability of remission in panic disorder (Barlow et al,
2000). From a mechanistic perspective, the limited clinical
impact of combination regimes indicates that the two forms
of treatment are unlikely to interact synergistically, rather it
suggests that either they act independently or actively
interfere with each other. If, as hypothesized (Browning
et al, 2010a), alterations of affective processing bias mediate
the treatments’ clinical effects, then one of these patterns of
interaction (independence or interference) should be
observed when the impact of combined treatment on
affective processing is studied.
This prediction was tested using a factorial experimental
design (see Figure 1b) in which non-clinical participants
were administered 7 days of the selective serotonin reuptake
inhibitor (SSRI) citalopram or a placebo while completing
either an active (positive) or a control cognitive bias
training task, which was designed to alter attentional bias.
In addition to measures of affective processing bias, the
impact of interventions on emotional resilience was
assessed using subjective ratings of depression and anxiety
in response to a negative mood induction. The specific
predictions tested were that each active intervention (ie,
citalopram and positive cognitive bias training), when
administered individually, would induce relatively positive
processing biases and increase subsequent emotional
resilience. As discussed above, the results from clinical
trials suggest that a synergistic interaction between treat-
ments is unlikely; therefore, we hypothesized either no
interaction or active interference between the two interven-
tions, although we had no strong rationale for selecting
between these options.
MATERIALS AND METHODS
Participants
A total of 64, fluent English-speaking participants who were
judged to be healthy on the basis of a medical screen and
Figure 1 Study design and bias training task used. (a) Participants completed two assessment sessions, immediately before and after the period of
treatment. The assessment measures completed during both sessions are listed. (b) Each participant was randomly assigned to one of four treatment groups
using a factorial design. This design allows assessment of the main effects of both citalopram and training type, as well as the interaction of the two. (c) Two
example trials from the attentional bias training task completed by participants. On each trial, two faces were presented, followed by a probe (one or two
dots) to which participants had to respond. During positive training (shown), the probe appeared behind the more positive of the two faces on the majority
of trials; the control training condition was identical in every respect other than that the probe was equally likely to appear behind either face.
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also screened to exclude current or previous axis I
psychiatric disorder or alcohol/substance misuse using the
Structured Clinical Interview for the DSM-IV (Spitzer et al,
2002). Other exclusion criteria included taking any psy-
choactive medication, any significant neurological condi-
tion, familiarity with the tasks or stimuli used in the study,
or any contraindication to taking SSRI medication. After
complete description of the study to participants, written
informed consent to the study, which had been approved by
a Local NHS Research Ethics Committee, was obtained.
Participants were randomized into one of the four treatment
groups (see Figure 1b). Treatments were administered for 7
days. Participants were assessed immediately before and
after treatment (see Figure 1a). Two participants in the
citalopram group experienced side effects (one nausea and
one insomnia), which prevented completion of the study
and resulted in data being available for 62 participants. For
female participants, the study was completed outside the
premenstrual week.
Questionnaire Measures
Participants completed questionnaire assessments of
depressive (Beck Depression Inventory (Beck et al, 1961))
and anxious symptomatology (Trait subscale of the State-
Trait Anxiety Inventory (Spielberger et al, 1983)) as well as
state measures of anxiety (state-STAI) and mood (Positive
and Negative Affect Scale (PANAS); Watson et al, 1988)
both before and after treatment.
Experimental Interventions
Pharmacological intervention. All participants were pro-
vided with 7 days supply of either citalopram 20mg or
lactose placebo capsules. The capsules were identical in
appearance, and participants were instructed to take them
every morning, starting on the following morning and
including the day of post-treatment assessment.
Cognitive bias training. The cognitive bias training task
used (Figure 1c) was a computerized, face-based, visual-
probe training (MacLeod et al, 2002), which has been
developed to alter attentional bias to emotional informa-
tion. Similar tasks have been found to improve symptoms of
anxiety and depression (Hakamata et al, 2010; Wells and
Beevers, 2009). On the basis of the widely used dot-probe
task (MacLeod et al, 1986), a pair of facial expressions
(Lundqvist et al, 1998; Matsumoto and Ekman, 1988;
Tottenham et al, 2009), was briefly presented and followed
by a probe (one or two dots), which appeared behind one of
the faces. The faces displayed positive (happy), neutral, or
negative (fearful and angry) expressions with each trial of
the task displaying faces from two different valences
(vertical visual angle of stimuli E111, vertical separation
of stimuli E3.51). This resulted in three possible face pair
types: positive-neutral, positive-negative, and negative-
neutral. The positive training condition included a majority
(87.5%) of trials in which the probe replaced the relatively
positive face (ie, during negative-neutral trials, the neutral
face is relatively more positive, whereas during happy-
neutral or happy-negative trials, the happy face is more
positive). When completing the positive training, participants
learn to deploy their attention toward the relatively positive
face as this predicts the probe location; that is, they develop a
positive attentional bias. Control training was identical in
every respect other than the location of the probe, which was
equally often found behind the positive and negative faces.
A single session of the task involved two blocks of 48 trials
each (each block included 16 trials of the three different face
pair combinations). The blocks differed in the duration of
time the stimuli were presented (500 or 1000ms). Previous
studies of attentional bias training have tended to use a more
restricted range of stimuli valence and presentation dura-
tions. However, a concern with using only one type of
training trial is that it will limit the degree to which the effects
of training generalize from the laboratory to real-world
experiences, which is believed to be essential if training is to
have a meaningful clinical effect (MacLeod et al, 2009). This
concern has prompted recent studies of attentional bias
training to deploy various trial types (Hayes et al, 2010) and
motivated the range of stimuli valence and presentation times
used in the current study. All participants completed the
training sessions twice daily at home (Blackwell and Holmes,
2010) using a laptop computer, which was supplied to them
for the duration of the study.
Compliance with interventions. Compliance with both
pharmacological and bias training interventions was
encouraged by providing participants with a log book in
which they recorded the date and time that medication had
been taken and training completed. In addition, partici-
pants were contacted by researchers on three occasions
during the treatment week to check whether they were
complying with the study protocol.
Assessment Tasks
Emotional word categorization task; assessing emotional
bias for self referential information. In all, 60 personality
characteristics selected to be extremely disagreeable (eg,
hostile) or agreeable (honest; taken from the study by
Anderson (1968)) were presented on the computer screen
for 500ms. These words were matched in terms of word
length, ratings of frequency, and meaningfulness (Harmer
et al, 2004). Participants were asked to categorize whether
they would be pleased or upset if they overheard someone
else referring to them as possessing the characteristic
described by the words, so that the judgment was in part
self-referring. Categorization bias is estimated by compar-
ing the mean reaction times to categorize positive vs
negative words.
Emotional memory task; assessing memory bias. Recogni-
tion and recall of the personality trait words presented in
the emotional word categorization task was also assessed
(Harmer et al, 2004). During the recognition task,
volunteers were asked to indicate whether they recognized
the word for each item on a list containing the 60 targets
along with 60 matched distractors (30 likeable and 30
dislikeable). Recall was assessed simply by asking partici-
pants to list as many words as they could remember from
the categorization task. Memory bias is reflected in the
relative number of positive vs negative words correctly
recognized or recalled.
Visual-probe task; assessing attentional bias. A face-based
visual-probe task (MacLeod et al, 1986), was completed
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intervention had altered attentional function. The task was
similar to the bias training task in that attention to a novel
set of positive, negative, and neutral faces were assessed (the
set of face stimuli used in training vs testing was counter-
balanced between participants). During the task, probe
location was balanced between the relatively more negative
and positive stimuli, and deployment of attention was
assessed using blocks of trials in which the stimuli were
presented for either 100ms or for the durations used in
training (500 and 1000ms, order of blocks counter-
balanced). This resulted in a total of 144 trials. Importantly,
this task is able to assess whether the attentional bias
training produced, as expected, a generalized tendency to
divert attention away from negative and toward positive
information as opposed to a more limited effect on a
specific stimuli valence. The estimate of attentional bias is
obtained by comparing the mean reaction time when
the probe replaces the relatively negative vs positive face
(Wilson and MacLeod, 2003).
Mood induction task; assessing emotional reactivity to
external events. To assess emotional reactivity to external
events, participants were required to complete a mood
induction task (Clark, 1983; Velten, 1968). During the task
(Holmes et al, 2009), participants listened to sad music
(Russia under the Mongolian Yoke by Prokofiev played at
50% normal speed) while reading negative self-referent
statements on the computer screen (‘It seems such an effort
to do anything’). Such procedures have been reliably shown
to produce increased negative mood in non-clinical groups
(Clark, 1983). State measures of negative mood (negative-
PANAS) and anxiety (state-STAI) were taken before and
after the task with the critical outcome being the change in
these scores induced by the task.
Statistical Analysis
Mixed model analyses of variance (ANOVAs) were con-
structed with the between-subject factors of medication
(citalopram, placebo) and training (positive, control). This
resulted in estimates of the effect of each active intervention
(ie, main effects of training and medication) and, critically,
an interaction term (medication training), which assesses
for the presence of positive or negative interactions. The
emotional word categorization and memory tasks included
a single within-subject factor, word valence (positive,
negative). Addition of the within-subject factor of test
time to the analyses of the questionnaire measures, visual
probe, and mood induction tasks allowed changes in
these outcomes across time to be assessed. The visual
probe task included additional within-subject factors
coding for the face pairs presented (positive-neutral,
positive-negative, negative neutral). and the durations the
face stimuli were presented for (100, 500, 1000ms), which
allowed assessment of whether the training effect was
influenced by any of these factors. Baseline questionnaire
and demographic measures were analyzed using univariate
ANOVAs. After inspection of the data, extreme reaction
times (outside 200–800ms for the visual probe task and
200–1600ms for the categorization task) were removed
before calculating the mean.
RESULTS
Demographic and Baseline Data
The groups were well matched in terms of age, gender, and
baseline scores on mood and anxiety measures (see Table 1),
indicating that randomization had been successful. There
was no effect of either intervention or their interaction on
change in any of the baseline measures listed in Table 1 (all
p40.14).
Effects of Interventions on Emotional Biases
Emotional memory. As shown in Figure 2a, the individual
interventions of positive training plus placebo or control
training plus citalopram produced a relative increase in the
number of positive vs negative words recognized, compared
with control training plus placebo. In contrast, co-admin-
istration of the interventions (positive training plus
citalopram) produced no change in memory bias at all.
Thus, there was interference between the two interventions
for the emotional memory task (Figure 2a; training 
medication emotion; F¼5.1, df¼1,58, p¼0.03).
This effect on overall emotional bias was driven by a
pronounced training medication interaction for recogni-
tion of negative words (Figure 2b; F¼12.6, df¼1,58,
p¼0.001), with a similar pattern being found, to a
significantly reduced extent, for the recognition of positive
words (not illustrated; F¼4.4, df¼1,58 p¼0.04). Post hoc
analysis (Figure 2b) revealed that each intervention on its
own produced a significant reduction in the number of
negative words recognized, whereas the combination of
interventions produced no change from baseline. Indeed,
the combined intervention group displayed increased
recognition memory for negative words when compared
with the individual intervention groups.
Analysis of the number of words recalled, as opposed to
recognized, revealed no significant effects of either inter-
vention or their interaction (all p40.38).
Emotional word categorization. The speed of word
categorization also displayed an interference effect with a
similar pattern to that displayed in word recognition
(Figure 2c; training medication emotion; F¼4.5,
df¼1,58, p¼0.04). Thus, participants who received a single
active intervention displayed a decrease in the reaction time
to categorize negative vs positive words, whereas the
combination group displayed less effect. Post hoc analysis
comparing the differences between the groups did not reach
statistical significance.
Did Bias Training Alter Attentional Function?
As expected, positive attentional bias training, when
compared with control training, led to a general increase
in attentional bias toward positive faces (training 
time probe location; F¼7.0, df¼1,58, p¼0.01). This
effect was not modified by the duration at which the
stimuli were presented, the face pair types which were
presented, or the medication group (all p40.3). For further
analysis of the visual probe data, see Supplementary
Methods.
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Induction?
Citalopram protected participants against the negative
effects of the mood induction task (Figure 3). Relative to
participants who received placebo, those who took citalo-
pram (NB both the citalopram control and citalopram-
positive groups) displayed a smaller average increase in
negative-PANAS score (time drug; F¼6.9, df¼1,58,
p¼0.01). The cognitive bias training group (positive vs
control) did not influence emotional resilience (time 
training; F¼0.9, df¼1,58, p¼0.35) and there was no
interaction between the interventions (time drug train-
ing; F¼0.7, df¼1,58, p¼0.39). The results from the
emotional bias tasks suggest that the protective effect of
citalopram should be eroded in the group which also
completed positive bias training and, although an overall
interaction effect was not found in the omnibus ANOVA,
inspection of Figure 3 suggests such a pattern. Statistical
comparison of the citalopram control and citalopram-
positive groups indicated that this predicted effect was
present at a trend level (F¼3.6, df¼1, 29, p¼0.07).
Table 1 Summary of Demographic and Baseline Data From All Four Groups
Control training with
placebo (n¼16)
Positive training with
placebo (n¼15)
Control training with
citalopram (n¼15)
Positive training with
citalopram (n¼16)
p
a
Age mean (SD) 21.6 (2.4) 21.1 (1.8) 20.9 (2.6) 21.1 (2.4) 0.52
Gender F:M 8:8 8:7 8:7 8:8 0.80
b
BDI mean (SD) 3.7 (2.9) 3.9 (5.2) 2.6 (2.7) 2.9 (2.4) 0.24
Trait-STAI Mean (SD) 39 (7.6) 35 (8) 34.3 (6) 35.7 (7.7) 0.19
Neg-PANAS Mean (SD) 13 (3.2) 12.8 (6) 11.9 (1.6) 11.7 (2.3) 0.23
State-STAI Mean (SD) 29.6 (6.9) 29.8 (10.1) 29.2 (7) 29.4 (6.1) 0.80
Abbreviations: BDI, Beck Depression Inventory; PANAS, Positive and Negative Affect Scale; STAI, Spielberger State-Trait Anxiety Inventory.
aThe p-value reported is the lowest from either of the main effects (medication, training) or the interaction term (medication training).
bAnalysis performed using logistic regression model. All other analyses performed using univariate ANOVA.
Figure 2 Effects of interventions on measures of cognitive bias. (a) Emotional memory bias, calculated as the relative accuracy in the recognition of
positive vs negative words. An interference pattern is seen (F¼5.1, df¼1,58, p¼0.03); when compared with the baseline group (control placebo) both
interventions, administered singly, produce a relative increase in positive memory bias, whereas the combination treatment does not. (b) The interference
effect is apparent in the mean number of negative words recognized (F¼12.6, df¼1,58, p¼0.001). Both citalopram and positive training significantly
decrease recognition of negative words, whereas the combination of interventions does not differ from the baseline group and shows increased memory of
negative words compared with the singly administered interventions. The results of the post hoc pairwise comparisons are shown, *po0.05, ^po0.1.
(c) Emotional bias when categorizing self-referent words, calculated as the relative reaction time to classify negative vs positive words. A negative interference
pattern is again seen (F¼4.5, df¼1,58, p¼0.038), with each intervention administered singly reducing the relative reaction time difference between negative
and positive words, whereas the combination of interventions again has very little effect. All graphs display mean scores with error bars reporting SE.
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state-STAI, were not influenced by either intervention or
their interaction (all p40.5).
Were the Cognitive Effects of the Interventions Related
to their Effects on Emotional Reactivity?
If, as predicted (Harmer, 2008), the cognitive effects of the
interventions mediate their impact on emotional vulner-
ability, the emotional bias and vulnerability measures
should correlate within a treatment group. Consistent with
this, a significant positive correlation within citalopram-
treated participants was found between the number of
negative words recognized during the memory task and the
subsequent increase in the negative-PANAS score induced
by mood induction (r¼0.44, p¼0.01). No correlation was
found between these measures for the positive bias training
group (r¼ 0.29, p¼0.39).
DISCUSSION
The current study is the first to explore the interaction
between an SSRI and positive cognitive bias training on
biomarker measures relevant to depression and anxiety. In
line with predictions, concurrent administration of the
pharmacological and psychological active interventions was
found to produce an interference effect on measures of
emotional memory and categorization bias. Citalopram, but
not positive bias training, was found to protect against the
effects of the negative mood induction with the degree of
protection being predicted by the extent to which the drug
reduced memory for negative words. These results provide
a conceptual framework for starting to compare and
understand the mechanisms of treatment associated with
drugs on the one hand and aspects of psychological therapy
on the other, for emotional disorders.
The current study used an experimental medicine model
to test specific predictions about the mechanisms of
treatment interaction within a tightly controlled laboratory
setting (Browning et al, 2010a). In line with previous work,
both citalopram (Harmer et al, 2004; Murphy et al, 2009)
and positive cognitive bias training (Browning et al, 2010b;
MacLeod et al, 2002) on their own produced relatively
positive changes in emotional bias, consistent with the idea
that this may be a common process in treatments of
emotional disorders (Harmer, 2008). However, the critical
result from the current study is that combining the SSRI
with training of positive emotional bias reduced the effect of
either alone. As suggested in the ‘Introduction’ section, this
cognitive interference effect may provide a plausible
mechanism for the modest clinical impact of such
combination treatments. More generally, it suggests that
laboratory-based assessment of affective processing biases,
which is sensitive to the effects of both pharmacological and
psychological interventions, presents a valuable opportunity
to investigate the mechanisms underlying the interaction
between disparate treatments for anxiety and depression.
Using a biomarker model, the results from the current
study suggest that combining cognitive bias training of
attention with an SSRI may not be a useful intervention
strategy for depression and anxiety. Such an effect is
consistent with the hypothesis that intact amygdala function
is necessary for cognitive bias training to occur and that
SSRIs interfere with training by impairing amygdala
function (Browning et al, 2010a). However, this mechanism
does not explain why cognitive bias training was also found
to interfere with the effects of citalopram. If replicated, such
a pattern of results may indicate that generalization of the
effect of SSRIs to measures of mood and emotional memory
only occur when the medication is able to influence
participants’ interpretation of emotionally ambiguous
events. In other words, if individuals are presented only
with positive information (as is the case with positive
training), there may be no opportunity for the medication
to alter a maladaptive appraisal of the information and thus
to improve mood.
It is difficult to generalize these results to the combination
of SSRIs with full therapist-delivered CBT. However,
adopting an experimental psychopathology approach to
CBT suggests that it can be decomposed into theory-driven
constituent parts, which may be individually tested. Given
this, alteration of attentional processing bias, modeled in
the current study using the bias training task, is likely to be
only one of the many mechanisms by which complex
psychotherapies such as CBT improve mood and anxiety
and thus, other facets of CBT may be independent of, or
even interact synergistically with, SSRIs. For example,
although the current cognitive training regime has targeted
attentional bias, it would be interesting to consider whether
alteration of the other key biases associated with anxiety
Figure 3 Effects of the interventions on emotional reactivity across the
mood induction procedure. Measures of negative affect (negative-PANAS)
were taken before and after the mood induction task. As can be seen,
participants in the citalopram-treated groups (control citalopram and
positive citalopram) displayed a smaller increase in negative symptoms than
did those in the placebo groups (time drug; F¼6.9, df¼1,58, p¼0.01).
Direct comparison between the two citalopram-treated groups revealed a
trend level effect of training (F¼3.6, df¼1, 29, p¼0.07). Consistent with
the effects of the interventions on emotional biases, the addition of positive
bias training to citalopram tended to reduce the protective effect of
the drug.
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MacLeod, 2005), may complement the effects of SSRIs.
More broadly, other forms of pharmacotherapy may
interact positively with cognitive bias training regimes.
Indeed, an interesting recent study provides some evidence
that D-cycloserine may enhance the basic attentional bias
training effect (Behar et al, 2010). Perhaps the most
promising application of the experimental approach used
in the current study will involve identifying the specific
combinations of pharmacological and psychological inter-
ventions which complement each other, and then testing
whether treatment regimes that show potential in the
laboratory go on to deliver benefit in the clinic.
Citalopram, but not positive cognitive bias training, was
found to protect participants from the effects of a negative
mood induction. This is the first demonstration, to our
knowledge, that an SSRI can protect healthy volunteers from
the effects of negative mood induction in the laboratory and
critically, this effect was predicted by the degree to which the
medication reduced memory for negative words. Therefore,
these results are consistent with the proposal that alterations
in affective processing mediate the therapeutic effect of the
medication (Harmer, 2008). However, contrary to expecta-
tions, the change in bias produced by cognitive training was
not sufficient to alter mood resilience and did not mimic the
protective effects of the SSRI. A possible explanation for this
lack of effect is that the negative mood induction procedure
used in the current study may be more suited to
investigating depressive rather than anxious vulnerability.
Consistent with this, the protective effect of citalopram was
evident on a scale of negative affect (the negative-PANAS)
rather than a specific measure of anxiety (state-STAI).
Although there is evidence that attentional cognitive bias
training does ameliorate symptoms of depression, this
literature is less consistent (Baert et al, 2010; Wells et al,
2009) than that demonstrating an anxiolytic effect (Haka-
mata et al, 2010). Thus, the specific emotional challenge
used may not be optimal in detecting the impact of training
on subjective emotional experience.
Finally, some of the caveats in interpreting the results of
this study should be acknowledged. We have suggested that
our results may have clinical implications; however,
extrapolating these laboratory results to the clinic requires
two assumptions. First, it assumes that the degree of
affective bias change induced by a treatment is a reasonable
proxy for the clinical efficacy of that treatment, and second,
it assumes that the cognitive effects of the interventions
demonstrated in this study of healthy volunteers are an
accurate reflection of their effects in clinical populations.
Support for these assumptions is provided by previous
work, which has demonstrated that the initial effects of
antidepressants on affective bias predict later clinical
response (Tranter et al, 2009) and by the similarity between
the effects of the treatments on affective biases in non-
clinical and clinical populations (Harmer et al, 2004, 2009).
Furthermore, the finding that the cognitive effects of
citalopram predicted its protective effect during the mood
induction task supports a link between affective bias and
subjective mood. However, a more direct test of these
assumptions would obviously be provided by replicating the
current findings in a clinical sample. A second caveat is that
the stability and persistence of any cognitive bias training is
likely to be influenced both by the reliability of the
measures of cognitive bias (see Supplementary Materials
and Schmukle, 2005) and by the variability in the induced
bias itself (MacLeod et al, 2009; Schlam, 2008). As our study
was designed to test the immediate impact of interventions
on cognitive functioning and mood reactivity, we did not
assess the degree to which the induced biases persisted and
remained stable after completion of the treatment. Future
studies may be able to address this limitation by retesting
the effects of the treatments at later time points. Third, we
monitored compliance with the pharmacological aspect of
treatment using participants’ self-report only. It would have
been reassuring also to have access to serum citalopram
levels to objectively confirm compliance. Fourth, we did not
collect detailed information on participants’ family history
of depression. Given the previous finding that this factor is
associated with more pronounced negative mood effects of
tryptophan depletion (Klaassen et al, 1999), it would be
interesting to investigate whether it also mediated the
protective effects of citalopram found during the mood
induction task. Finally, it should also be acknowledged that
the sample sizes used in the study were relatively modest.
Thus, although the study was able to identify significant
interactions between the two treatments, other treatment
effects may not have been detected because of insufficient
power.
The current study has used an experimental medicine
approach to investigate how specific psychological and
pharmacological interventions for the emotional disorders
interact at the cognitive level. The results suggest that active
interference occurs between these two interventions such
that administering them concurrently produces a smaller
effect than when they are administered separately. This
provides a plausible conceptual framework for beginning to
investigate the modest clinical results seen when the two
forms of treatment are combined in clinical settings and
suggests that pinpointing the cognitive actions of treat-
ments may inform future development of combination
strategies in mental health.
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